Shum Financial Group Inc. Invests $2.31 Million in Johnson & Johnson $JNJ

Shum Financial Group Inc. bought a new stake in Johnson & Johnson (NYSE:JNJ) in the 3rd quarter, Holdings Channel.com reports. The firm bought 12,471 shares of the company’s stock, valued at approximately $2,312,000. Johnson & Johnson accounts for about 1.7% of Shum Financial Group Inc.’s holdings, making the stock its 18th largest position.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in Johnson & Johnson by 13.9% in the 4th quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock valued at $7,502,000 after purchasing an additional 6,332 shares during the last quarter. United Bank increased its stake in Johnson & Johnson by 110.7% in the first quarter. United Bank now owns 9,279 shares of the company’s stock valued at $1,539,000 after purchasing an additional 4,876 shares during the period. Investmark Advisory Group LLC raised its holdings in shares of Johnson & Johnson by 0.8% in the first quarter. Investmark Advisory Group LLC now owns 20,633 shares of the company’s stock valued at $3,422,000 after buying an additional 159 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Johnson & Johnson by 17.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 379,870 shares of the company’s stock worth $62,987,000 after buying an additional 56,040 shares during the period. Finally, NewEdge Advisors LLC grew its holdings in shares of Johnson & Johnson by 13.0% during the first quarter. NewEdge Advisors LLC now owns 333,821 shares of the company’s stock worth $55,361,000 after buying an additional 38,425 shares during the last quarter. Hedge funds and other institutional investors own 69.55% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on JNJ. Wells Fargo & Company lifted their target price on Johnson & Johnson from $212.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Scotiabank started coverage on shares of Johnson & Johnson in a research report on Thursday, November 13th. They issued a “sector outperform” rating and a $230.00 price objective on the stock. Daiwa America upgraded shares of Johnson & Johnson from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 20th. Guggenheim raised their target price on shares of Johnson & Johnson from $206.00 to $227.00 and gave the stock a “buy” rating in a research note on Friday, December 5th. Finally, Morgan Stanley boosted their price target on shares of Johnson & Johnson from $190.00 to $197.00 and gave the stock an “equal weight” rating in a research note on Friday, December 12th. Four equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $211.25.

Johnson & Johnson Stock Up 0.1%

JNJ stock opened at $207.26 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.07 and a quick ratio of 0.80. The company’s 50 day simple moving average is $201.17 and its 200-day simple moving average is $182.64. Johnson & Johnson has a 12 month low of $140.68 and a 12 month high of $215.18. The firm has a market capitalization of $499.35 billion, a PE ratio of 20.01, a P/E/G ratio of 2.12 and a beta of 0.34.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Wednesday, August 30th. The company reported $2.26 earnings per share (EPS) for the quarter. The firm had revenue of $24.02 billion for the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. Equities analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Tuesday, February 24th. Johnson & Johnson’s dividend payout ratio (DPR) is currently 50.19%.

Johnson & Johnson Profile

Johnson & Johnson is a multinational healthcare company headquartered in New Brunswick, New Jersey, that develops, manufactures and markets a broad range of products across pharmaceuticals, medical devices and previously consumer health. Founded in 1886 by the Johnson family, the company has grown into a global healthcare organization with operations and sales in many countries around the world.

The company’s pharmaceuticals business, organized largely under its Janssen research and development organization, focuses on prescription medicines across therapeutic areas such as immunology, infectious disease, oncology and neuroscience.